Competition Quote by Scott Gottlieb

One of the biggest factors fueling the angst over drug prices in the U.S. is that some older medicines that should be sold cheaply…

— Scott Gottlieb

The key to the generic-drug economic model is to keep entry prices low enough to attract multiple competitors.

— Scott Gottlieb

The regulatory approach of the Food and Drug Administration and the Patent and Trademark Office has driven up the costs of generic drugs.

— J. D. Vance

Increasing patient access to more affordable, FDA-approved generic and biosimilar medicines is a proven and tested solution to lowering prescription drug costs.

— Chris Sununu

One dirty tactic big pharmaceutical companies use is keeping drug prices artificially high through anti-competitive conduct, such as paying competitors millions of dollars to…

— Mike Braun

Getting a traditional pharmaceutical to the market can cost a billion dollars or more. Newer, more tailored and targeted drugs called biologics are even…

— David Mixner

“Generics were not created to be a differential advantage against other retailers but to help the retailer control the manufacturer, and they became an…

— Greg Thain

Competition is the best way to ensure prescription drugs are affordable.

— Amy Klobuchar

If you ask yourself who is paying for pharmaceutical innovation today, the answer is that it's the more affluent populations paying for still-patented advanced…

— Thomas Pogge

The value that the generic drug industry brings to the U.S. healthcare system is indisputable.

— Heather Bresch

We should look for ways to expedite generic drug approvals, particularly for products that have a long history of being safe and effective.

— Amy Klobuchar

The cost of prescription drugs in this country is far, far higher than in any other country. You may recall that Donald Trump as…

— Bernie Sanders